Lindbrook Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $613K | Buy |
5,469
+884
| +19% | +$99.1K | 0.06% | 193 |
|
2024
Q4 | $424K | Buy |
4,585
+403
| +10% | +$37.2K | 0.04% | 246 |
|
2024
Q3 | $351K | Buy |
4,182
+382
| +10% | +$32K | 0.03% | 276 |
|
2024
Q2 | $261K | Buy |
3,800
+929
| +32% | +$63.7K | 0.02% | 307 |
|
2024
Q1 | $210K | Sell |
2,871
-398
| -12% | -$29.2K | 0.02% | 351 |
|
2023
Q4 | $265K | Buy |
3,269
+883
| +37% | +$71.5K | 0.03% | 296 |
|
2023
Q3 | $179K | Sell |
2,386
-222
| -9% | -$16.6K | 0.02% | 345 |
|
2023
Q2 | $201K | Buy |
2,608
+195
| +8% | +$15K | 0.02% | 324 |
|
2023
Q1 | $200K | Sell |
2,413
-5,669
| -70% | -$470K | 0.02% | 312 |
|
2022
Q4 | $694K | Buy |
8,082
+6,717
| +492% | +$577K | 0.09% | 148 |
|
2022
Q3 | $84K | Buy |
1,365
+226
| +20% | +$13.9K | 0.01% | 491 |
|
2022
Q2 | $70K | Sell |
1,139
-6,131
| -84% | -$377K | 0.01% | 547 |
|
2022
Q1 | $432K | Buy |
7,270
+303
| +4% | +$18K | 0.07% | 178 |
|
2021
Q4 | $506K | Buy |
6,967
+34
| +0.5% | +$2.47K | 0.08% | 165 |
|
2021
Q3 | $484K | Buy |
6,933
+28
| +0.4% | +$1.96K | 0.13% | 71 |
|
2021
Q2 | $475K | Sell |
6,905
-36
| -0.5% | -$2.48K | 0.11% | 83 |
|
2021
Q1 | $449K | Buy |
6,941
+976
| +16% | +$63.1K | 0.1% | 80 |
|
2020
Q4 | $348K | Buy |
5,965
+17
| +0.3% | +$992 | 0.09% | 95 |
|
2020
Q3 | $376K | Sell |
5,948
-599
| -9% | -$37.9K | 0.1% | 83 |
|
2020
Q2 | $504K | Sell |
6,547
-105
| -2% | -$8.08K | 0.15% | 51 |
|
2020
Q1 | $497K | Buy |
6,652
+278
| +4% | +$20.8K | 0.19% | 44 |
|
2019
Q4 | $414K | Sell |
6,374
-30
| -0.5% | -$1.95K | 0.14% | 71 |
|
2019
Q3 | $406K | Sell |
6,404
-1,929
| -23% | -$122K | 0.15% | 65 |
|
2019
Q2 | $562K | Buy |
8,333
+1,344
| +19% | +$90.6K | 0.22% | 42 |
|
2019
Q1 | $454K | Buy |
6,989
+133
| +2% | +$8.64K | 0.18% | 56 |
|
2018
Q4 | $428K | Buy |
+6,856
| New | +$428K | 0.21% | 51 |
|